GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q1 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $822,717 | +203.4% | 18,900 | +203.6% | 0.79% | +253.1% |
| Q1 2022 | $271,161 | -5.0% | 6,225 | -3.9% | 0.22% | -3.0% |
| Q4 2021 | $285,548 | +8.0% | 6,475 | -6.4% | 0.23% | -1.3% |
| Q3 2021 | $264,413 | -11.9% | 6,920 | -8.1% | 0.23% | -35.5% |
| Q2 2021 | $300,000 | +11.5% | 7,530 | 0.0% | 0.36% | +45.2% |
| Q1 2021 | $269,000 | +15.9% | 7,530 | +19.2% | 0.25% | +13.1% |
| Q4 2020 | $232,000 | – | 6,315 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |